Aster Capital Management (Difc) LTD Wave Life Sciences Ltd. Transaction History
Aster Capital Management (Difc) LTD
- $262 Billion
- Q4 2024
A detailed history of Aster Capital Management (Difc) LTD transactions in Wave Life Sciences Ltd. stock. As of the latest transaction made, Aster Capital Management (Difc) LTD holds 858 shares of WVE stock, worth $9,274. This represents 0.0% of its overall portfolio holdings.
Number of Shares
858
Previous 12,285
93.02%
Holding current value
$9,274
Previous $101 Million
89.46%
% of portfolio
0.0%
Previous 0.02%
Shares
2 transactions
Others Institutions Holding WVE
# of Institutions
196Shares Held
123MCall Options Held
323KPut Options Held
279K-
Ra Capital Management, L.P. Boston, MA18.2MShares$197 Million3.65% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA9.62MShares$104 Million0.22% of portfolio
-
Lee Ainslie Maverick Capital LTD | Dallas, Tx8.26MShares$89.3 Million1.98% of portfolio
-
Black Rock Inc. New York, NY6.74MShares$72.8 Million0.0% of portfolio
-
Driehaus Capital Management LLC Chicago, IL6.71MShares$72.6 Million0.81% of portfolio
About Wave Life Sciences Ltd.
- Ticker WVE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 86,820,096
- Market Cap $939M
- Description
- Wave Life Sciences Ltd., a clinical stage genetic medicine company, designs, optimizes, and produces novel stereopure oligonucleotides through PRISM, a discovery and drug developing platform. It is developing oligonucleotides target ribonucleic acid to reduce the expression of disease-promoting proteins or restore the production of functional pr...